cefonicid has been researched along with cefuroxime in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (58.33) | 18.7374 |
1990's | 3 (25.00) | 18.2507 |
2000's | 2 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barry, AL; Doern, GV; Ferraro, MJ; Jorgensen, JH; Murray, PR | 1 |
Efrati, Z; Keness, J; Raz, R | 1 |
Jordan, FM; Kawahara, NE | 1 |
Glatt, AE | 1 |
Ayers, LW; Barry, AL; Fuchs, PC; Gavan, TL; Gerlach, EH; Jones, RN; Thornsberry, C | 1 |
Bosso, JA; Marble, DA; Townsend, RJ | 1 |
Bergman, MM; Gleckman, RA | 1 |
Polk, RE; Tartaglione, TA | 1 |
Blue, D; Rapp, RP | 1 |
Benson, JM; Boudinot, FD; Cunningham, FE; DiPiro, JT; Pennell, AT | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
2 review(s) available for cefonicid and cefuroxime
Article | Year |
---|---|
Second-generation cephalosporins.
Topics: Bacterial Infections; Bacteroides Infections; Cefamandole; Cefazolin; Cefonicid; Cefoxitin; Cefuroxime; Cephalosporins; Gonorrhea; Haemophilus Infections; Humans; Respiratory Tract Infections; Structure-Activity Relationship | 1986 |
Review of the new second-generation cephalosporins: cefonicid, ceforanide, and cefuroxime.
Topics: Bacteria; Bacterial Infections; Cefamandole; Cefonicid; Cefuroxime; Cephalosporins; Costs and Cost Analysis; Humans; Kinetics | 1985 |
10 other study(ies) available for cefonicid and cefuroxime
Article | Year |
---|---|
Development of revised quality control limits for disk diffusion susceptibility tests of selected cephem antibiotics with Haemophilus influenzae and description of a new control strain.
Topics: Ampicillin; Cefaclor; Cefamandole; Cefonicid; Cefuroxime; Cephalosporins; Evaluation Studies as Topic; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Quality Control; Reference Standards | 1992 |
Cefonicid versus cefuroxime: an in vitro study of 1,000 Enterobacteriaceae.
Topics: Cefonicid; Cefuroxime; Drug Resistance, Microbial; Enterobacteriaceae; Escherichia coli; Humans; Microbial Sensitivity Tests | 1992 |
Influencing prescribing behavior by adapting computerized order-entry pathways.
Topics: Cefonicid; Cefuroxime; Chicago; Computer Systems; Drug Prescriptions; Drug Utilization; Hospital Bed Capacity, 500 and over; Hospitals, Teaching; Pharmacy and Therapeutics Committee; Pharmacy Service, Hospital | 1989 |
Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicid.
Topics: Anti-Bacterial Agents; Aztreonam; Cefamandole; Cefonicid; Cefotaxime; Ceftazidime; Ceftizoxime; Ceftriaxone; Cefuroxime; Enterococcus faecalis; Escherichia coli; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Quality Control; Thienamycins | 1987 |
Compatibility of clindamycin phosphate with aztreonam in polypropylene syringes and with cefoperazone sodium, cefonicid sodium, and cefuroxime sodium in partial-fill glass bottles.
Topics: Aztreonam; Cefamandole; Cefonicid; Cefoperazone; Cefuroxime; Cephalosporins; Clindamycin; Drug Combinations; Drug Incompatibility; Drug Packaging; Drug Stability; Syringes | 1988 |
Newer antibiotics: their place in geriatric care. Part I.
Topics: Bacterial Infections; Cefamandole; Cefazolin; Cefonicid; Cefotetan; Cefoxitin; Cefuroxime; Cephalosporins; Cephamycins; Geriatrics; Humans | 1986 |
The role of the extended half-life second-generation cephalosporins in surgical prophylaxis.
Topics: Cefamandole; Cefonicid; Cefuroxime; Cephalosporins; Half-Life; Humans; Premedication; Surgical Wound Infection | 1985 |
In vitro protein binding of cefonicid and cefuroxime in adult and neonatal sera.
Topics: Adult; Aging; Blood Proteins; Cefonicid; Cefuroxime; Dose-Response Relationship, Drug; Humans; Infant, Newborn; Kinetics; Protein Binding | 1993 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |